Cargando…

Management of life-threatening hemoptysis

It is estimated that 5–14% of patients presenting with hemoptysis will have life-threatening hemoptysis, with a reported mortality rate between 9 and 38%. This manuscript provides a comprehensive literature review on life-threatening hemoptysis, including the etiology and mechanisms, initial stabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Kathuria, Hasmeena, Hollingsworth, Helen M., Vilvendhan, Rajendran, Reardon, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132983/
https://www.ncbi.nlm.nih.gov/pubmed/32280479
http://dx.doi.org/10.1186/s40560-020-00441-8
_version_ 1783517540859772928
author Kathuria, Hasmeena
Hollingsworth, Helen M.
Vilvendhan, Rajendran
Reardon, Christine
author_facet Kathuria, Hasmeena
Hollingsworth, Helen M.
Vilvendhan, Rajendran
Reardon, Christine
author_sort Kathuria, Hasmeena
collection PubMed
description It is estimated that 5–14% of patients presenting with hemoptysis will have life-threatening hemoptysis, with a reported mortality rate between 9 and 38%. This manuscript provides a comprehensive literature review on life-threatening hemoptysis, including the etiology and mechanisms, initial stabilization, and management of patients. There is no consensus on the optimal diagnostic approach to life-threatening hemoptysis, so we present a practical approach to utilizing chest radiography, computed tomography, and bronchoscopy, alone or in combination, to localize the bleeding site depending on patient stability. The role of angiography and embolization as well as bronchoscopic and surgical techniques for the management of life-threatening hemoptysis is reviewed. Through case presentation and flow diagram, an overview is provided on how to systematically evaluate and treat the bronchial arteries, which are responsible for hemoptysis in 90% of cases. Treatment options for recurrent hemoptysis and definitive management are discussed, highlighting the role of bronchial artery embolization for recurrent hemoptysis.
format Online
Article
Text
id pubmed-7132983
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71329832020-04-11 Management of life-threatening hemoptysis Kathuria, Hasmeena Hollingsworth, Helen M. Vilvendhan, Rajendran Reardon, Christine J Intensive Care Review It is estimated that 5–14% of patients presenting with hemoptysis will have life-threatening hemoptysis, with a reported mortality rate between 9 and 38%. This manuscript provides a comprehensive literature review on life-threatening hemoptysis, including the etiology and mechanisms, initial stabilization, and management of patients. There is no consensus on the optimal diagnostic approach to life-threatening hemoptysis, so we present a practical approach to utilizing chest radiography, computed tomography, and bronchoscopy, alone or in combination, to localize the bleeding site depending on patient stability. The role of angiography and embolization as well as bronchoscopic and surgical techniques for the management of life-threatening hemoptysis is reviewed. Through case presentation and flow diagram, an overview is provided on how to systematically evaluate and treat the bronchial arteries, which are responsible for hemoptysis in 90% of cases. Treatment options for recurrent hemoptysis and definitive management are discussed, highlighting the role of bronchial artery embolization for recurrent hemoptysis. BioMed Central 2020-04-05 /pmc/articles/PMC7132983/ /pubmed/32280479 http://dx.doi.org/10.1186/s40560-020-00441-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Kathuria, Hasmeena
Hollingsworth, Helen M.
Vilvendhan, Rajendran
Reardon, Christine
Management of life-threatening hemoptysis
title Management of life-threatening hemoptysis
title_full Management of life-threatening hemoptysis
title_fullStr Management of life-threatening hemoptysis
title_full_unstemmed Management of life-threatening hemoptysis
title_short Management of life-threatening hemoptysis
title_sort management of life-threatening hemoptysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132983/
https://www.ncbi.nlm.nih.gov/pubmed/32280479
http://dx.doi.org/10.1186/s40560-020-00441-8
work_keys_str_mv AT kathuriahasmeena managementoflifethreateninghemoptysis
AT hollingsworthhelenm managementoflifethreateninghemoptysis
AT vilvendhanrajendran managementoflifethreateninghemoptysis
AT reardonchristine managementoflifethreateninghemoptysis